drugset / Trial / NCT00126087

Potentiation of Procedural Motor Learning in Health and Disease

NCT00126087 ↗

Phase 4 Terminated 18 enrolled University Hospital Muenster
RandomizedCrossoverDouble-blindTreatment

Summary

The investigators plan to improve the learning of motor skills by pharmacological means (dopamine), and by noninvasive brain stimulation. They will study both healthy subjects and chronic stroke patients. In addition, they want to study the mechanisms of enhanced learning, on the molecular and the systems level.

Timeline

Start
2005-07
Primary completion
2007-12
Completion
2013-01

Outcome

Met primary endpoint

Stopped (Enrollment): “no further funding available for recruiting and testing participants”

paper Levodopa significantly improved our primary outcome measure, procedural motor learning, compared with placebo (P<.05). PMID 18760148 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Unknown 100 mg —

Indications